Abstract:The vascular wall is the first physiologic barrier that circulating nanoparticles (NPs) encounter, which also is a key biological barrier to cancer drug delivery. NPs can continually scavenge the endothelium for biomarkers of cancer, and the chance of NPs' extravasation into the tumors can be enhanced. Here, we envision P-selectin as a target for specific delivery of drug nanocrystals to tumors. The cupric diethyldithiocarbamate nanocrystals (CuET NCs) were first prepared by an antisolvent method, and then nanocrystals were coated with fucoidan via physical interaction. The fucoidan-coated CuET nanocrystals () possess high drug loading and have the ability to interact with human umbilical vein endothelial cells expressing P-selectin, which transiently enhances the endothelial permeability and facilitates extravasation from the peritumoral vascular to achieve higher tumor accumulation of drugs than bare CuET NCs. The CuET NC shows poorer anticancer efficacy than at the same dose of CuET. Upon repeated dosing of for 2 weeks, no mortality was observed in treated melanoma-bearing mice, while the mortality in the control group and excipient-treated groups reached 23%. The growth rate of melanoma in the group was significantly lower than those in other groups. Furthermore, an acute toxicity study revealed that is a safe formulation for cancer treatment.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c09346.Characterization of fucoidan-Coated copper diethyldithiocarbamate nanocrystals (), cytotoxicity of the CuET NCs and in vitro, live/dead staining of B16F10 cells after 24 h of treatment with CuET NCs, representative flow cytometry analysis of competitive inhibition of binding to HUVECs, expression of P-selectin in main organs from C57BL/6 mice; survival and weight of C57BL/6 mice in the acute toxicity test within 1 week, H&E staining of C57BL/6 mice in the acute toxicity test within 1 week, blood routine analysis of C57BL/6 mice after anticancer treatment, and weight of melanoma-bearing C57BL/6 mice during the two-week anticancer Experiment (PDF)This article has not yet been cited by other publications.

Targeting Delivery Nanocarriers for (+)-Terrein to Enhance Its Anticancer Effects

Intracellular Restructured Reduced Glutathione-Responsive Peptide Nanofibers for Synergetic Tumor Chemotherapy

Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy

A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions

Targeted Anti-Cancer Therapy: Co-Delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-Modified Lipid Nanoparticles for Enhanced Anti-Angiogenic Efficacy

Hyaluronic acid-conjugated methotrexate and 5-fluorouracil for targeted drug delivery

Biointerface engineering of self-protective bionic nanomissiles for targeted synergistic chemotherapy

Surface Decoration via Physical Interaction of Cupric Diethyldithiocarbamate Nanocrystals and Its Impact on Biodistribution and Tumor Targeting

Developing liver-targeted naringenin nanoparticles for breast cancer endocrine therapy by promoting estrogen metabolism

Synthesis and Evaluation of Targeted Nanomicelle Delivery System with Rhein As the Hydrophobic End and Its Synergistic Therapy Effect on Tumor

CD44 targeting nanodrug based on chondroitin sulfate for melanoma therapy by inducing mitochondrial apoptosis pathways

Cell Membrane-Coated Nanoparticles for Tumor-Targeted Drug Delivery

Nanotheranostics With the Combination of Improved Targeting, Therapeutic Effects, and Molecular Imaging

Redox Stimuli-Responsive Hollow Mesoporous Silica Nanocarriers for Targeted Drug Delivery in Cancer Therapy

Boosting ferroptosis and microtubule inhibition for antitumor therapy via a carrier-free supermolecule nanoreactor

Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44

Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity

FeS2@COF Based Nanocarrier for Photothermal-Enhanced Chemodynamic/thermodynamic Tumor Therapy and Immunotherapy Via Reprograming Tumor-Associated Macrophages

Tumor Cells-Specific Targeting Delivery Achieved by A54 Peptide Functionalized Polymeric Micelles

Targeted Delivery of Arctigenin Using Sialic Acid Conjugate-Modified Liposomes for the Treatment of Breast Cancer

Enhanced antitumor effect of icariin nanoparticles coated with iRGD functionalized erythrocyte membrane